Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease.
about
Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancerSerum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease.Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinomaPlasma-Mediated Gut Protection After Hemorrhagic Shock is Lessened in Syndecan-1-/- Mice.Association Between Affective-Cognitive Symptoms of Depression and Exacerbation of Crohn's Disease.Suppressing Syndecan-1 Shedding Ameliorates Intestinal Epithelial Inflammation through Inhibiting NF-κB Pathway and TNF-αCell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis.Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.
P2860
Q33761544-F914E1AE-DD00-486A-A62E-1A3B838DD40DQ34499650-212351E4-740A-487A-9969-D9087D72C52BQ35942018-4E50B6DB-9DC2-43C3-95E0-7FE3FDD64981Q36325314-40A7926B-4801-418F-AFD2-21EF167C4F9FQ36752489-D14F691B-0B0B-4B33-8312-69771BC32B30Q37137336-5E5E869C-F44F-48FD-B2B1-A19254D21441Q37192894-60743F30-B1F8-40DB-BF8C-71F67A6D5C0FQ37539888-EF04885C-48D5-4A4D-82C8-DF7F29468CEAQ38721699-4FFDF740-A288-4CF8-8D40-5F65F4BFEE87Q38831882-9F656A1E-A495-4043-B877-0288A36377CCQ40341695-0CEEF927-1C3B-4900-A1F1-081693D74D82Q47842891-306A5AB1-0822-40AE-A340-FD6FB0AB170BQ47852995-12ECACB7-787A-4010-8A54-511EBAFA78CB
P2860
Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@en
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@nl
type
label
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@en
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@nl
prefLabel
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@en
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@nl
P2093
P2860
P1476
Syndecan-1 and heparanase: pot ...... diagnosis of Crohn's disease.
@en
P2093
Fachao Zhi
Qunying Wang
Shaoheng Zhang
Yali Zhang
P2860
P304
P356
10.1097/MIB.0B013E318280298F
P577
2013-04-01T00:00:00Z